指南与共识前列腺癌

晚期前列腺癌:AUA/ASTRO/SUO 指南第一部分

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
指南 / 共识 · J Urol · 2020-09-22

本指南第一部分针对局部治疗后生化复发无转移及转移性激素敏感前列腺癌患者,提供预后与治疗推荐。系统综述由独立方法学顾问完成,检索 Ovid MEDLINE、Cochrane 图书馆等数据库并更新至 2020 年 1 月 20 日,专家组制定循证与共识声明。

要点

  • 指南覆盖生化复发无转移和转移性激素敏感前列腺癌。
  • 推荐基于系统综述与专家共识制定。
  • 转移性去势抵抗疾病的管理见第二部分。

核心结论

  • 指南旨在提高临床医生治疗晚期前列腺癌患者的能力。
  • 未来高质量试验证据对改善这些患者的照护水平至关重要。

研究设计与样本

  • 方法学团队补充检索了既往 AUA 综述纳入的研究及相关文章参考文献列表。
  • 晚期前列腺癌专家组制定循证与共识指南声明。

关键数值与推荐

  • 指南声明汇总于图 1 并在文中详述。

临床怎么用

  • 临床医生可依据指南声明管理生化复发无转移和转移性激素敏感前列腺癌患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The summary presented herein represents Part I of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with biochemical recurrence without metastatic disease after exhaustion of local treatment options as well as those with metastatic hormone-sensitive prostate cancer. Please refer to Part II for discussion of the management of castration-resistant disease. MATERIALS AND METHODS: The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. A research librarian conducted searches in Ovid MEDLINE (1998 to January Week 5 2019), Cochrane Central Register of Controlled Trials (through December 2018), and Cochrane Database of Systematic Reviews (2005 through February 6, 2019). An updated search was conducted prior to publication through January 20, 2020. The methodology team supplemented searches of electronic databases with the studies included in the prior AUA review and by reviewing reference lists of relevant articles. RESULTS: The Advanced Prostate Cancer Panel created evidence- and consensus-based guideline statements to aid clinicians in the management of patients with advanced prostate cancer. Such statements are summarized in figure 1[Figure: see text] and detailed herein. CONCLUSIONS: This guideline attempts to improve a clinician's ability to treat patients diagnosed with advanced prostate cancer. Continued research and publication of high-quality evidence from future trials will be essential to improve the level of care for these patients.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Lowrance WT, Breau RH, Chou R, et al. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. J Urol. 2020. PMID: 32960679. doi:10.1097/JU.0000000000001375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。